December 2006 Newsletter

Table of Contents:

• President's Message
• Meeting Review: 10th Annual ICCVA Meeting
• 2007 Preliminary Supporters and Exhibitors


• Literature Reviews
  • Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
  • A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.
  • Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?
  • Methylene blue added to a hypertonic-hyperoncotic solution increases short-term survival in experimental cardiac arrest.


• Drug and Innovation Update
  • Levosimendan: The Next Dobutamine?

• Complete December 2006 Newsletter

Archived Newsletter Articles

© Society of Cardiovascular Anesthesiologists
Questions or comments? Please send email to webmaster@scahq.org